HQY icon

HealthEquity

87.42 USD
-2.40
2.67%
At close Aug 25, 4:00 PM EDT
After hours
87.42
+0.00
0.00%
1 day
-2.67%
5 days
-2.29%
1 month
-8.98%
3 months
-13.57%
6 months
-18.64%
Year to date
-9.70%
1 year
15.09%
5 years
59.93%
10 years
209.56%
 

About: HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Employees: 3,120

0
Funds holding %
of 7,429 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

56% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 50

16% more capital invested

Capital invested by funds: $8.1B [Q1] → $9.39B (+$1.29B) [Q2]

14% more funds holding in top 10

Funds holding in top 10: 7 [Q1] → 8 (+1) [Q2]

4% more funds holding

Funds holding: 460 [Q1] → 478 (+18) [Q2]

1% more repeat investments, than reductions

Existing positions increased: 173 | Existing positions reduced: 172

10% less call options, than puts

Call options by funds: $19.9M | Put options by funds: $22.1M

2.53% less ownership

Funds ownership: 106.26% [Q1] → 103.73% (-2.53%) [Q2]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$104
19%
upside
Avg. target
$118
34%
upside
High target
$125
43%
upside

7 analyst ratings

positive
86%
neutral
14%
negative
0%
Raymond James
C. Gregory Peters
37%upside
$120
Strong Buy
Reiterated
8 Jul 2025
Barrington Research
Alexander Paris
43%upside
$125
Outperform
Maintained
5 Jun 2025
Deutsche Bank
George Hill
32%upside
$115
Buy
Maintained
5 Jun 2025
Goldman Sachs
David Roman
19%upside
$104
Neutral
Maintained
4 Jun 2025
RBC Capital
Daniel Perlin
34%upside
$117
Outperform
Maintained
4 Jun 2025

Financial journalist opinion

Based on 5 articles about HQY published over the past 30 days

Positive
Zacks Investment Research
1 week ago
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY's HSA growth, AI-driven efficiencies, and strong Q1 results fuel optimism despite data security concerns.
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Neutral
GlobeNewsWire
1 week ago
CORRECTION - HealthEquity Community Foundation Expands National Impact with $50,000 in Grants
Funding supports 20 nonprofit organizations focused on physical and mental health, financial literacy, and basic needs as the foundation grows and welcomes a new leader Funding supports 20 nonprofit organizations focused on physical and mental health, financial literacy, and basic needs as the foundation grows and welcomes a new leader
CORRECTION - HealthEquity Community Foundation Expands National Impact with $50,000 in Grants
Positive
Zacks Investment Research
2 weeks ago
OGN vs. HQY: Which Stock Is the Better Value Option?
Investors interested in Medical Services stocks are likely familiar with Organon (OGN) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
OGN vs. HQY: Which Stock Is the Better Value Option?
Neutral
Seeking Alpha
2 weeks ago
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses, guidance cuts, and Medicare Advantage mispricing, despite its long-term potential to restore profitability. Thermo Fisher and argenx detracted from performance amid macro headwinds and lower-than-expected sales, but we retain conviction in their long-term prospects.
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Neutral
GlobeNewsWire
2 weeks ago
HealthEquity Announces Dates to Report Second Quarter Earnings and Presentations at Investor Conferences
DRAPER, Utah, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans to release its second quarter of fiscal 2026 financial results following the close of regular stock market trading hours on Tuesday, September 2, 2025. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, September 2, 2025, at 4:30 p.m. Eastern Time during which management will review the Company's financial results.
HealthEquity Announces Dates to Report Second Quarter Earnings and Presentations at Investor Conferences
Positive
Zacks Investment Research
1 month ago
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
Positive
Zacks Investment Research
1 month ago
HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?
Positive
Zacks Investment Research
1 month ago
HealthEquity (HQY) Upgraded to Buy: Here's Why
HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
HealthEquity (HQY) Upgraded to Buy: Here's Why
Positive
Zacks Investment Research
1 month ago
GDRX vs. HQY: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
GDRX vs. HQY: Which Stock Is the Better Value Option?
Positive
Kiplinger
1 month ago
The Best Growth Stocks to Buy
Growth stocks can create significant returns for investors, but what are they and how do you find the best ones? We take a closer look here.
The Best Growth Stocks to Buy
Charts implemented using Lightweight Charts™